Specific cardiac considerations include: Heart rhythm concerns: The heart rate-increasing effect may require additional monitoring in patients with atrial fibrillation, supraventricular tachycardia, or ventricular arrhythmias Heart failure: Patients with New York Heart Association (NYHA) Class III-IV heart failure were excluded from major clinical trials, and there is limited safety data in this population [18] [21] Recent cardiac events: Patients with recent myocardial infarction, stroke, or unstable angina may require individualized assessment during the recovery period Hemodynamic considerations: Rapid weight loss may affect fluid balance in patients with significant cardiac disease Adverse effects relevant to cardiac patients include gastrointestinal symptoms (nausea, vomiting, diarrhea) that may lead to dehydration and electrolyte disturbances

For researchers considering a switch from semaglutide to tirzepatide , the 10mg dose is often the target maintenance level after completing the escalation schedule
The complex pathogenesis of AD involves oxidative stress, which induces several cellular damages in keratinocytes, impairs skin barrier function, and exacerbates the inflammatory response
One small in vivo human study showed topical soybean phytosterols sped up barrier recovery within three days on tape-stripped skin